Targeting Cancer-associated fibroblasts by magnetic nanoparticles and magnetic field exposure to disrupt tumor microenvironment

Y Lalatone, Véronique Gigoux(Centre National de la Recherche Scientifique), J. Carrey(Centre National de la Recherche Scientifique), Laurence Motte(Inserm), Pascal Clerc(Centre de Recherche en Cancérologie de Toulouse), N Halalli, Corinne Bousquet(Centre National de la Recherche Scientifique), Dominique Fourmy
HAL (Le Centre pour la Communication Scientifique Directe)
October 1, 2019
Cited by 0

Related Papers

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter
|Proceedings of the National Academy of Sciences|1999|290
Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma
|The Journal of Pathology|2018|284
International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
|Pharmacological Reviews|2018|251